All In MedTech

Device Trial Radar · NCT04241224

A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular Blockages

Last checked: Nov 20, 2026Latest source record: Jan 17, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

108

Actual

Start

Feb 26, 2020

Primary completion

May 31, 2022

Study completion Nov 17, 2022

Sponsor

Lead sponsor
Ra Medical SystemsNot on our public-company list
Sponsor type
Industry
First posted
Jan 27, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and effectiveness of the DABRA Laser System in the atherectomy of peripheral vascular stenoses.

Conditions

  • Peripheral Arterial Disease

Interventions

  • AtherectomyDevice

    Endovascular treatment of peripheral arterial disease

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Technical SuccessTime frame: At Index Procedure

1 more outcomes with a free account

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • California Heart & Vascular Clinic

    El Centro, California

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.